Labetalol, a beta-blocker with alpha-blocking activity, can effectively manage hypertension in autoimmune patients by reducing arterial pressure. However, it may mask hypoglycemia symptoms or exacerbate Raynaud’s phenomenon, complicating management in those with conditions like diabetes or scleroderma.